Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GSK
Biotech
GSK loses R&D leader—Chutes & Ladders
GSK shake-up has R&D head John Lepore out the door. BenevolentAI CEO steps down. Lonza loses CEO—again.
Gabrielle Masson
,
Max Bayer
Sep 22, 2023 9:30am
GSK shuffles R&D as research head John Lepore heads out the door
Sep 18, 2023 3:16pm
After initial stumbles, Moderna gets clean win for mRNA flu shot
Sep 13, 2023 6:30am
CureVac hand-picks mRNA flu vaccine but keeps data tucked away
Sep 12, 2023 10:45am
GSK identifies bacterium with malaria-fighting potential
Aug 7, 2023 3:10pm
'On our minds': Novartis, GSK mull IRA impact on R&D strategies
Jul 26, 2023 11:06am